Rare diseases
Investigational molecules
Locations
Study on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis
SwedenStudy of Patisiran for Patients with Transthyretin Amyloidosis and Heart Disease
SwedenStudy on Treating Metastatic Castration-Resistant Prostate Cancer with 177Lu-PNT2002 Compared to Abiraterone or Enzalutamide for Patients After Hormonal Therapy
SwedenStudy of PF-07220060 and Fulvestrant for Adults with Advanced or Metastatic HR-positive, HER2-negative Breast Cancer After Previous Treatment
SwedenStudy on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis
SwedenStudy of secukinumab and prednisone combination therapy for patients with giant cell arteritis (GCA): Evaluation of treatment effectiveness and safety
SwedenStudy on Palbociclib and Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer
SwedenStudy on Acalabrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients Without del(17p) or TP53 Mutation
SwedenStudy of Encorafenib, Cetuximab, and Pembrolizumab for Patients with Untreated BRAF V600E-Mutant Metastatic Colorectal Cancer
SwedenStudy of Tucatinib and Ado-Trastuzumab Emtansine for Patients with Advanced HER2+ Breast Cancer
SwedenStudy on the Safety and Tolerability of Oral Dersimelagon for Patients with Erythropoietic Protoporphyria or X-Linked Protoporphyria
SwedenStudy on Enzalutamide and Leuprorelin Acetate for Men with High-Risk Nonmetastatic Prostate Cancer After Treatment
SwedenTell us about your condition – we search every trial in Europe and connect you with the right site.
